Literature DB >> 28582639

Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels.

Lina Sabor1, Mélanie Raphaël2, Jean-Michel Dogné2, François Mullier1, Jonathan Douxfils3.   

Abstract

Entities:  

Keywords:  Apixaban; Chromogenic anti-Xa assays; Edoxaban; Heparin; Rivaroxaban

Mesh：

Substances：

Year:  2017        PMID： 28582639     DOI： 10.1016/j.thromres.2017.05.024

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?

Authors:  Ravi Sarode
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay.

Authors:  Cheryl L Maier; William H Asbury; Alexander Duncan; Adele Robbins; Ann Ingle; Adam Webb; Sean R Stowell; John D Roback
Journal:  Am J Hematol       Date:  2019-02-21       Impact factor: 10.047

3.  Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.

Authors:  Tamana Meihandoest; Jan-Dirk Studt; Adriana Mendez; Lorenzo Alberio; Pierre Fontana; Walter A Wuillemin; Adrian Schmidt; Lukas Graf; Bernhard Gerber; Ursula Amstutz; Cedric Bovet; Thomas C Sauter; Lars M Asmis; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-03-17

4.  Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.

Authors:  Sandra Margetić; Ivana Ćelap; Diana Delić Brkljačić; Nikola Pavlović; Sandra Šupraha Goreta; Ivana Kobasić; Arijana Lovrenčić-Huzjan; Vanja Bašić Kes
Journal:  Biochem Med (Zagreb)       Date:  2019-12-15       Impact factor: 2.313
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.